The biotech company Lorus has announced the enrollment of the first cancer patient in a Phase I clinical study evaluating its small molecule anticancer drug candidate LOR-253. The open-label, dose escalation study will enroll patients with advanced or metastatic solid tumors for which no effective therapy is currently available, or whose cancer has not responded to conventional or standard ther...

Robotica / Volume 29 / Issue 02 / March 2011, pp 245 253 DOI: 10.1017/S026357471000010X, Published online: 30 April 2010 Link to this article: http://journals.cambridge.org/abstract_S026357471000010X How to cite this article: Jingzhou (James) Yang, Tim Marler and Salam Rahmatalla (2011). Multi-objective optimization-based method for kinematic posture prediction: development and validation. Robo...